The arrival of Retatrutide ZPHC, at a dosage of 120mg, is generating considerable buzz within the weight loss community. This novel dual GIP and GLP-1 agonist medication seems to deliver impressive improvements in fat reduction compared to previous therapies. Preliminary research data have indicated substantial reductions in body mass , conceivably